Treatment and prevention of peritoneal carcinomatosis from gastric cancer by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Overview and rationale |
| |
| Authors: | F. Roviello S. CarusoA. Neri D. Marrelli |
| |
| Affiliation: | Department of Human Pathology and Oncology, Section of General Surgery and Surgical Oncology, University of Siena, Viale Bracci-Policlinico “Le Scotte”, 53100 Siena, Italy |
| |
| Abstract: | ![]()
Peritoneal carcinomatosis (PC) from gastric cancer is a condition with a very bleak prognosis. Most authors consider it to be a terminal disease and recommend palliative therapy only. Multimodal therapeutic approaches to PC have emerged in the last decades, combining cytoreductive surgery (CRS) and peritonectomy procedures with perioperative intraperitoneal chemotherapy (IPEC), including hyperthermic intraperitoneal chemotherapy (HIPEC) and/or early postoperative intraperitoneal chemotherapy (EPIC). |
| |
| Keywords: | Gastric cancer Peritoneal carcinomatosis Perioperative intraperitoneal chemotherapy Hyperthermic intraperitoneal chemotherapy |
| 本文献已被 ScienceDirect 等数据库收录！ |
